Tag: Vaccines

During period of delta predominance, protection was lower among vaccinated persons without previous COVID-19 diagnosis

Compared with homologous booster, heterologous booster with mRNA-based vaccine yielded larger increase in binding antibodies

But protection against COVID-19 hospitalization, death after two doses of BNT162b2 or CHAdOx1-S is more durable

Chances of hospitalization for COVID-19 more than 40 times higher for those who are unvaccinated than for those with full vaccination and booster

Fourth dose of mRNA vaccine increased antispike IgG titers in some kidney transplant recipients with weak serologic response after three doses

Two doses of RZV recommended for adults 19 years and older who are immunocompromised due to disease or therapy

Two doses highly effective against COVID-19-related hospitalization and critical illness for those aged 12 to 18 years

Thirty-six of the organization's 194 member countries have still only vaccinated 10 percent of their populations

The NCCN Advisory Committee supports the strong preference for mRNA vaccines and offers guidance on the timing of vaccination